Master protocol for mantle cell lymphomaA multicenter phase II trial testingGemcitabine for the treatment of patients with newlydiagnosed, relapsed or chemotherapy resistantmantle cell lymphomaProtocol SAKK 36/03
Comparing two schedules of rituximab maintenance in rituximab-responding patients with untreated, chemotherapy resistant or relapsed follicular lymphoma: A randomized phase III trial